Increased production of reactive oxygen species by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells

Journal of Toxicological Sciences

Volumn 37, Issue 5, 2012, Pages 1045-1048

  Yokomakura, Aya ^a,b   Hong, JangJa ^c   Ohuchi, Kazuo ^c   Oh, Seong Eun ^a   Lee, Jin Yong ^a,d   Mano, Nariyasu ^b   Takahashi, Tsutomu ^a   Hwang, Gi Wook ^a   Naganuma, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c Mibyou Pharmacy Research Center   (South Korea)

^d AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Bafilomycin A1; Concanamycin A; RAW 264 cells; Reactive oxygen species; V ATPase inhibitor

Indexed keywords

ACETYLCYSTEINE; BAFILOMYCIN A1; CONCANAMYCIN A; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL CELL; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; LETTER; LEUKEMIA CELL LINE; MOUSE; NONHUMAN;

EID: 84867871921     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.1045     Document Type: Letter

References (16)

1. Carmody, R.J. and Cotter, T.G. (2001): Signalling apoptosis: a radical approach. Redox Rep., 6, 77-90.
2. Chandra, J., Samali, A. and Orrenius, S. (2000): Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med., 29, 323-333.
3. Farina, C. and Gagliardi, S. (1999): Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents. Drug Discov. Today, 4, 163-172.
4. Fehrenbach, E. and Northoff, H. (2001): Free radicals, exercise, apoptosis, and heat shock proteins. Exerc. Immunol. Rev., 7, 66-89.
5. Finkel, T. and Holbrook, N.J. (2000): Oxidants, oxidative stress and the biology of ageing. Nature, 408, 239-247.
6. Hwang, G.W., Tobita, M., Takahashi, T., Kuge, S., Kita, K. and Naganuma, A. (2010): siRNA-mediated AMPKalpha1 subunit gene PRKAA1 silencing enhances methylmercury toxicity in HEK293 cells. J. Toxicol. Sci., 35, 601-604.
7. Hwang, G.W., Ryoke, K., Lee, J.Y., Takahashi, T. and Naganuma, A. (2011): siRNA-mediated silencing of the gene for heat shock transcription factor 1 causes hypersensitivity to methylmercury in HEK293 cells. J. Toxicol. Sci., 36, 851-853.
8. Hong, J., Nakano, Y., Yokomakura, A., Ishihara, K., Kim, S., Kang, Y.S. and Ohuchi, K. (2006): Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells. J. Pharmacol. Exp. Ther., 319, 672-681.
9. Keeling, D.J., Herslöf, M., Ryberg, B., Sjögren, S. and Sölvell, L. (1997): Vacuolar H+-ATPases. Targets for drug discovery? Ann. N Y. Acad. Sci., 834, 600-608.
10. Kim, K.Y., Yu, S.N., Lee, S.Y., Chun, S.S., Choi, Y.L., Park, Y.M., Song, C.S., Chatterjee, B. and Ahn, S.C. (2011): Salinomycininduced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem. Biophys. Res. Commun., 413, 80-86.
11. Martindale, J.L. and Holbrook, N.J. (2002): Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol., 192, 1-15.
12. Nelson, N. (1991): Structure and pharmacology of the proton-ATPases. Trends Pharmacol. Sci., 12, 71-75.
13. Su, Y.W., Chiou, W.F., Chao, S.H., Lee, M.H., Chen, C.C. and Tsai, Y.C. (2011): Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways. Int. Immunopharmacol., 11, 1166-1172.
14. Wieczorek, H., Brown, D., Grinstein, S., Ehrenfeld, J. and Harvey, W.R. (1999): Animal plasma membrane energization by protonmotive V-ATPases. Bioessays, 21, 637-648.
15. Zhang, Y., Fong, C.C., Wong, M.S., Tzang, C.H., Lai, W.P., Fong, W.F., Sui, S.F. and Yang, M. (2005): Molecular mechanisms of survival and apoptosis in RAW 264.7 macrophages under oxidative stress. Apoptosis, 10, 545-556.
16. Zhang, Y.H., Wu, Y.L., Tashiro, S.I., Onodera, S. and Ikejima, T. (2011): Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol. Sin., 32, 1266-1275.